SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-071704
Filing Date
2024-06-14
Accepted
2024-06-14 15:04:39
Documents
1
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417330-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417330-3_4seq1.xml 4 5946
  Complete submission text file 0001104659-24-071704.txt   7422
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EYENOVIA INC 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address
JACOBSON RACHEL (Reporting) CIK: 0001911725 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 241044355